Lipid Metabolism Practice Questions

Q: Dietary fats are transported from the gastrointestinal tract to adipocytes in what form?

Chylomicrons. ### Explanation **Correct Answer: D. Chylomicrons** The transport of dietary (exogenous) lipids is a multi-step process. After ingestion, dietary triacylglycerols (TAGs) are broken down into free fatty acids and 2-monoacylglycerols in the intestinal lumen. These are absorbed by the enterocytes, where they are **re-esterified back into TAGs**. Because TAGs are hydrophobic, they cannot travel freely in the blood. They are packaged into **Chylomicrons**—large lipoprotein particles containing a core of TAGs and cholesteryl esters, surrounded by phospholipids and **Apolipoprotein B-48**. These chylomicrons enter the lymphatic system (lacteals) and eventually the bloodstream to deliver fats to adipocytes and muscle. **Why the other options are incorrect:** * **A & B (Diacylglycerol/Triacylglycerol):** While TAGs are the primary lipid being transported, they are insoluble in plasma. They must be packaged into a lipoprotein (Chylomicron) to be transported from the gut to peripheral tissues. * **C (Fat micelles):** Micelles are temporary aggregates of mixed lipids and bile salts formed within the **intestinal lumen** to facilitate absorption into the enterocyte. They do not enter the circulation. **High-Yield NEET-PG Pearls:** * **Apo B-48** is the characteristic structural marker for chylomicrons (formed via RNA editing of the Apo B gene). * **Lipoprotein Lipase (LPL)**, activated by **Apo C-II**, is the enzyme on capillary walls that hydrolyzes chylomicron TAGs for uptake by adipocytes. * **Milky serum** after a fatty meal is due to the presence of chylomicrons. * **Abetalipoproteinemia** is a clinical condition where a deficiency in Microsomal Triglyceride Transfer Protein (MTP) prevents chylomicron formation, leading to fat malabsorption and steatorrhea.

Q: Which of the following is a primary ketone body?

Acetoacetate. **Explanation:** Ketone bodies are produced in the liver mitochondria during states of high fatty acid oxidation (e.g., starvation, uncontrolled diabetes). The process, known as ketogenesis, follows a specific enzymatic sequence that determines which ketone body is "primary." **1. Why Acetoacetate is the Correct Answer:** Acetoacetate is termed the **primary ketone body** because it is the first ketone body synthesized in the liver. The pathway involves the condensation of Acetyl-CoA molecules to form HMG-CoA, which is then cleaved by **HMG-CoA lyase** to produce Acetoacetate. All other ketone bodies are derived from this parent molecule. **2. Analysis of Incorrect Options:** * **B. Acetone:** This is a secondary ketone body formed by the **spontaneous (non-enzymatic) decarboxylation** of acetoacetate. It is metabolic waste, cannot be utilized for energy, and is excreted via the lungs (causing "fruity breath"). * **C. Beta-hydroxybutyrate:** This is also a secondary ketone body formed by the **enzymatic reduction** of acetoacetate by the enzyme *β-hydroxybutyrate dehydrogenase*. While it is the most abundant ketone body in the blood during ketosis, it is chemically a derivative of acetoacetate. * **D. All are primary:** Incorrect, as only acetoacetate is the initial product of the ketogenic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Ketogenesis:** Liver mitochondria (but the liver **cannot** utilize ketones because it lacks the enzyme **Thiophorase/β-ketoacyl-CoA transferase**). * **Rate-limiting enzyme:** HMG-CoA Synthase (Mitochondrial). * **Detection:** The **Rothera’s Test** detects Acetoacetate and Acetone, but **not** Beta-hydroxybutyrate. * **Energy Yield:** Beta-hydroxybutyrate provides more ATP than Acetoacetate because it starts at a more reduced state (NADH is generated during its conversion back to acetoacetate in peripheral tissues).

Q: Which of the following biochemical changes is not indicative of hyperlipidemia type II-A?

HDL increased. ### Explanation **Fredrickson Classification of Hyperlipoproteinemias** is a high-yield topic for NEET-PG. To answer this question, one must understand the specific lipoprotein elevation associated with **Type II-A Hyperlipidemia** (also known as Familial Hypercholesterolemia). #### Why "HDL increased" is the Correct Answer: In Type II-A hyperlipidemia, the primary defect is a **deficiency or dysfunction of LDL receptors**. This leads to a selective elevation of **Low-Density Lipoprotein (LDL)**. High-Density Lipoprotein (HDL) levels are typically normal or may even be slightly decreased in various hyperlipidemias; an *increase* in HDL is not a diagnostic feature of Type II-A. Therefore, it is the "incorrect" clinical finding among the options. #### Analysis of Incorrect Options: * **A. Total cholesterol increased:** Since LDL is rich in cholesterol, its accumulation significantly raises the total serum cholesterol levels (often >300 mg/dL in heterozygotes). * **B. Triglycerides normal:** This is a pathognomonic feature of Type II-A. Unlike Type II-B (which has elevated VLDL), Type II-A involves only LDL elevation, meaning triglyceride levels remain within the reference range. * **C. LDL increased:** This is the hallmark of Type II-A. The lack of functional LDL receptors prevents the clearance of LDL from the plasma. #### Clinical Pearls for NEET-PG: * **Type II-A (Familial Hypercholesterolemia):** Associated with **Tendon Xanthomas** (especially the Achilles tendon) and Xanthelasma. * **Type II-B:** Elevated LDL + VLDL (increased Cholesterol + Triglycerides). * **Type I & V:** Characterized by milky plasma due to high Chylomicrons. * **Type III (Dysbetalipoproteinemia):** Associated with **Palmar Xanthomas** and elevation of IDL (Broad-beta disease).

Q: Which of the following lipids lacks fatty acids?

Cholesterol. ### Explanation **Correct Answer: C. Cholesterol** **Why Cholesterol is the correct answer:** Lipids are broadly classified into simple, complex, and derived lipids. **Cholesterol** is a **derived lipid** with a steroid nucleus (cyclopentanoperhydrophenanthrene ring). Unlike triglycerides or phospholipids, it does not contain fatty acids in its basic structure. While it can esterify with a fatty acid to form a *cholesterol ester* for storage or transport, the cholesterol molecule itself is a sterol, not an ester of fatty acids. **Analysis of Incorrect Options:** * **A. Glycerol:** While glycerol itself is a trihydroxy alcohol and not a lipid, in the context of lipid metabolism questions, it is often confused with **Glycerides**. However, if the option implies neutral fats (Triacylglycerols), they are esters of glycerol and three **fatty acids**. * **B. Waxes:** These are simple lipids consisting of long-chain **fatty acids** esterified with long-chain monohydric alcohols. * **D. Lipoprotein:** These are complex aggregates (like Chylomicrons, LDL, HDL) that transport lipids in the blood. They contain phospholipids, triglycerides, and cholesterol esters, all of which contain **fatty acids**. **High-Yield Clinical Pearls for NEET-PG:** * **Precursor Role:** Cholesterol is the essential precursor for **Steroid hormones** (cortisol, estrogen, testosterone), **Vitamin D**, and **Bile acids**. * **Membrane Fluidity:** Cholesterol inserts into cell membranes to regulate fluidity; it increases fluidity at low temperatures and decreases it at high temperatures. * **Amphipathic Nature:** Cholesterol is weakly amphipathic due to the hydroxyl (-OH) group at the C3 position. * **Rate-Limiting Enzyme:** HMG-CoA Reductase is the rate-limiting enzyme for cholesterol synthesis (target of Statins).

Q: What is the effect of lipotropic agents on fat metabolism?

Increases the rate of lipid output from the liver. **Explanation:** **Lipotropic agents** are substances required for the normal mobilization of fat from the liver. The correct answer is **B** because these agents facilitate the synthesis of **Very Low-Density Lipoproteins (VLDL)**. Triglycerides synthesized in the liver cannot be exported as free molecules; they must be packaged into VLDL particles. This process requires phospholipids (like lecithin) and apolipoproteins (Apo B-100). Lipotropic agents (e.g., Choline, Methionine, Betaine, and Inositol) provide the building blocks for these phospholipids. By increasing VLDL assembly, they ensure the efficient export (output) of lipids from the liver to peripheral tissues, thereby preventing the pathological accumulation of fat. **Analysis of Incorrect Options:** * **Option A:** Lipotropic agents do not stimulate fatty acid synthesis (lipogenesis); rather, they manage the disposal of existing lipids. * **Options C & D:** These agents do not primarily target the HMG-CoA reductase pathway or the rate of cholesterol synthesis; their main role is the transport and mobilization of triglycerides. **Clinical Pearls for NEET-PG:** * **Fatty Liver (Steatosis):** A deficiency of lipotropic agents leads to an accumulation of triglycerides in hepatocytes because they cannot be exported, resulting in non-alcoholic fatty liver disease (NAFLD). * **Choline & Methionine:** Choline is a precursor for phosphatidylcholine (lecithin). Methionine is a lipotropic agent because it acts as a methyl donor for the synthesis of choline. * **VLDL:** Remember that VLDL is the primary vehicle for transporting endogenous triglycerides from the liver to the extrahepatic tissues.

Q: Which of the following is NOT an essential fatty acid?

Palmitic acid. **Explanation:** **Essential Fatty Acids (EFAs)** are fatty acids that the human body cannot synthesize de novo because humans lack the enzymes (**desaturases**) capable of introducing double bonds beyond the $\Delta^9$ position. Therefore, they must be obtained through the diet. **Why Palmitic Acid is the Correct Answer:** Palmitic acid (C16:0) is a **saturated fatty acid**. It is the primary product of the Fatty Acid Synthase (FAS) complex in the cytoplasm. Since the body can synthesize it from Acetyl-CoA (derived from excess carbohydrates or proteins), it is considered **non-essential**. **Analysis of Incorrect Options:** * **Linoleic acid (C18:2, $\omega$-6):** A true essential fatty acid. It serves as the precursor for arachidonic acid. * **Linolenic acid (C18:3, $\omega$-3):** A true essential fatty acid. It is vital for cardiovascular health and is a precursor for EPA and DHA. * **Arachidonic acid (C20:4, $\omega$-6):** It is considered **semi-essential**. While it can be synthesized from linoleic acid, it becomes essential if linoleic acid is deficient in the diet. In the context of this question, it is categorized with the essential group. **High-Yield Clinical Pearls for NEET-PG:** 1. **Deficiency Manifestations:** EFA deficiency leads to **Phrynoderma** (follicular hyperkeratosis/toad skin), poor wound healing, and hair loss. 2. **The $\Delta^9$ Rule:** Humans possess $\Delta^4, \Delta^5, \Delta^6,$ and $\Delta^9$ desaturases. We cannot introduce double bonds at $\Delta^{12}$ or $\Delta^{15}$, which is why Linoleic ($\Delta^{9,12}$) and Linolenic ($\Delta^{9,12,15}$) acids are essential. 3. **Energy Yield:** Palmitic acid oxidation yields **106 ATP** (net) via the $\beta$-oxidation pathway.

Q: Which organ does not utilize ketone bodies?

Liver. **Explanation:** The **Liver** is the correct answer because, although it is the primary site of ketone body synthesis (ketogenesis), it lacks the essential enzyme required for their utilization (ketolysis). **1. Why the Liver cannot utilize ketone bodies:** Ketone body utilization requires the conversion of acetoacetate back into acetoacetyl-CoA. This step is catalyzed by the enzyme **Succinyl-CoA:3-ketoacid CoA-transferase (also known as Thiophorase)**. The liver lacks this enzyme. This deficiency is a physiological protective mechanism, ensuring that ketone bodies produced by the liver are exported to extrahepatic tissues for energy during fasting or starvation, rather than being consumed by the liver itself. **2. Why other options are incorrect:** * **Brain:** During prolonged starvation, the brain adapts to use ketone bodies (specifically 3-hydroxybutyrate and acetoacetate) as its primary energy source, meeting up to 75% of its energy requirements to spare glucose. * **Skeletal and Cardiac Muscles:** These tissues possess high levels of Thiophorase. In the early stages of fasting, muscles are the primary consumers of ketone bodies to conserve glucose for the brain. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of Ketogenesis:** HMG-CoA Synthase (Mitochondrial). * **Ketone bodies include:** Acetone (non-metabolizable, excreted in breath), Acetoacetate, and β-Hydroxybutyrate. * **Key Enzyme for Ketolysis:** Thiophorase (absent in liver). * **Site of Ketogenesis:** Mitochondria of hepatocytes. * **Clinical Sign:** "Fruity odor" of breath in Diabetic Ketoacidosis (DKA) is due to the excretion of acetone.

Question 1

Dietary fats are transported from the gastrointestinal tract to adipocytes in what form?

Accepted Answer

Chylomicrons

Answer

Diacylglycerol

Answer

Triacylglycerol

Answer

Fat micelles

Question 2

Which of the following sources of cholesterol is most important for sustaining adrenal steroidogenesis when it occurs at a high rate for a long time?

Accepted Answer

Cholesterol in LDL particles

Answer

De novo synthesis of cholesterol from acetate

Answer

Cholesterol in the plasma membrane

Answer

Cholesterol in lipid droplets within adrenal cortical cells

Question 3

Which of the following is a primary ketone body?

Accepted Answer

Acetoacetate

Answer

Acetone

Answer

Beta-hydroxybutyrate

Answer

All are primary ketone bodies

Question 4

Which of the following biochemical changes is not indicative of hyperlipidemia type II-A?

Accepted Answer

HDL increased

Answer

Total cholesterol increased

Answer

Triglycerides normal

Answer

LDL increased

Question 5

Which lipoprotein's receptors on blood cells accept cholesterol?

Accepted Answer

LDL

Answer

HDL

Answer

VLDL

Answer

Chylomicrons

Question 6

Which of the following lipids lacks fatty acids?

Accepted Answer

Cholesterol

Answer

Glycerol

Answer

Waxes

Answer

Lipoprotein

Question 7

Glucocorticoids and NSAIDs are used to treat inflammatory conditions, but they differ in their use for asthma. Which of the following statements most accurately describes the biochemical mechanism underlying this difference?

Accepted Answer

Steroids inhibit the production of all eicosanoids by blocking phospholipase A2, whereas NSAIDs selectively inhibit the production of prostaglandins and thromboxanes by blocking cyclooxygenase.

Answer

NSAIDs inhibit the production of all eicosanoids by blocking cyclooxygenase, whereas steroids selectively inhibit the production of leukotrienes by blocking lipoxygenase.

Answer

NSAIDs inhibit the production of leukotrienes and prostaglandins by blocking lipoxygenase and cyclooxygenase, whereas steroids inhibit the production of thromboxanes and leukotrienes by blocking cyclooxygenase and lipoxygenase.

Answer

Steroids inhibit the production of leukotrienes and prostaglandins by blocking phospholipase A2, whereas NSAIDs inhibit the production of leukotrienes and thromboxanes by blocking lipoxygenase and cyclooxygenase.

Question 8

What is the effect of lipotropic agents on fat metabolism?

Accepted Answer

Increases the rate of lipid output from the liver

Answer

Increases the rate of fatty acid synthesis in the liver

Answer

Increases the rate of cholesterol synthesis in the liver

Answer

Decreases the rate of cholesterol synthesis in the liver

Question 9

Which of the following is NOT an essential fatty acid?

Accepted Answer

Palmitic acid

Answer

Arachidonic acid

Answer

Linoleic acid

Answer

Linolenic acid

Question 10

Which organ does not utilize ketone bodies?

Accepted Answer

Liver

Answer

Brain

Answer

Skeletal muscles

Answer

Cardiac muscles

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?